Postprandial lipemia is not increased in patients with previous unprovoked venous thromboembolism

被引:1
|
作者
Hald, Erin M. [1 ,2 ]
Braekkan, Sigrid K. [1 ]
Vik, Anders [1 ,2 ]
Brodin, Ellen E. [1 ,2 ]
Hansen, John-Bjarne [1 ,2 ]
机构
[1] Univ Tromso, Dept Clin Med, Hematol Res Grp HERG, N-9037 Tromso, Norway
[2] Univ Hosp N Norway, Div Internal Med, Tromso, Norway
关键词
Venous; Thromboembolism; Postprandial lipemia; Risk factors; Cardiovascular disease; HIGH-DENSITY-LIPOPROTEIN; CARDIOVASCULAR RISK-FACTORS; SUBCLINICAL ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; ELDERLY SURVIVORS; HORMONE-THERAPY; HEART-DISEASE; THROMBOSIS; TRIGLYCERIDES; CHOLESTEROL;
D O I
10.1016/j.jacl.2012.06.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Patients with arterial cardiovascular disease have increased postprandial lipemia, and plasma levels of postprandial remnants are related to the progression of atherosclerosis. Studies have shown that patients with unprovoked venous thromboembolism have increased risk of arterial cardiovascular disease. OBJECTIVE: To investigate whether patients with a history of unprovoked venous thromboembolism have increased postprandial lipemia. METHODS: A population-based case control study was performed in 20 patients with a history of unprovoked venous thromboembolism and 20 age- and gender-matched healthy controls. Participants were subjected to a standard fat tolerance test (1 g/kilo body weight) with subsequent blood sampling every second hour for 8 hours. Lipids were measured by traditional methods and lipoprotein subclasses by proton nuclear magnetic resonance. RESULTS: Fasting lipids and lipoprotein subclasses did not differ between groups. The postprandial lipemia, assessed by the incremental area under the triglyceride curve, was not different in venous thromboembolism patients and healthy controls (5.0 +/- 3.6 mmol/L*h vs 5.3 +/- 4.4 mmol/L*h, P = .81). Similarly, the distribution and size of the lipoprotein subclasses obtained 4 hours postprandially did not differ between groups. CONCLUSION: Patients with a history of unprovoked venous thromboembolism had similar lipoprotein subclasses size, distribution, and postprandial lipemia as healthy controls. Our findings indicate that postprandial lipemia is not a link between unprovoked venous thromboembolism and arterial cardiovascular disease. C) 2013 National Lipid Association. All rights reserved.
引用
收藏
页码:48 / 55
页数:8
相关论文
共 50 条
  • [21] Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
    Robertson, Lindsay
    Yeoh, Su Ern
    Ram, Ahmad
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (12):
  • [22] Factors That Predict Risk of Thrombosis in Relatives of Patients With Unprovoked Venous Thromboembolism
    Couturaud, Francis
    Leroyer, Christophe
    Julian, Jim A.
    Kahn, Suan R.
    Ginsberg, Jeffrey S.
    Wells, Philip S.
    Douketis, James D.
    Mottier, Dominique
    Kearon, Clive
    CHEST, 2009, 136 (06) : 1537 - 1545
  • [23] Effect of occult cancer screening on mortality in patients with unprovoked venous thromboembolism
    Robin, Philippe
    Otten, Hans Martin
    Delluc, Aurelien
    van Es, Nick
    Carrier, Marc
    Salaun, Pierre-Yves
    Le Gal, Gregoire
    THROMBOSIS RESEARCH, 2018, 171 : 92 - 96
  • [24] EFFECTIVENESS AND SAFETY OF RIVAROXABAN VERSUS WARFARIN IN PATIENTS WITH UNPROVOKED VENOUS THROMBOEMBOLISM
    Coleman, Craig I.
    Bunz, Thomas J.
    Peacock, W. Frank
    Martinez, Brandon K.
    Baker, William L.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E12 - E12
  • [25] Prevalence of antiphospholipid antibodies in an Australian cohort of patients with unprovoked venous thromboembolism
    Ho, Wai Khoon
    Rigano, Joseph
    PATHOLOGY, 2018, 50 (05) : 580 - 581
  • [26] Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated
    Kearon, Clive
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (03) : 295 - 300
  • [27] D-Dimer Testing in Patients With a First Unprovoked Venous Thromboembolism
    Palareti, Gualtiero
    ANNALS OF INTERNAL MEDICINE, 2015, 162 (09) : 670 - 671
  • [28] A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (damoves)
    Moreno, A. I. F.
    Navarro, M. J. G.
    Sanchez, J. O.
    Diaz, R. M. M.
    Cerezo, E. M.
    de Ancos Aracil, C. L.
    Diaz, V. M.
    Garcia, A. G.
    Hernandez, C. M.
    Arponen, S.
    Clotet, N. C.
    Giardin, J. M. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 682 - 682
  • [29] Deciding on Treatment Duration for Unprovoked Venous Thromboembolism: What is Important to Patients?
    van de Brug, Anouk
    de Winter, Maria A.
    Ten Wolde, Marije
    Kaasjager, Karin
    Nijkeuter, Mathilde
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (04) : 600 - 610
  • [30] IDENTIFYING PATIENTS AT HIGH RISK OF CANCER AFTER UNPROVOKED VENOUS THROMBOEMBOLISM
    Veillet-Lemay, Gabrielle M.
    Carrier, Marc
    Le Gal, Gregoire
    Rodger, Marc A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (09) : E377 - E377